TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
24 hedge funds and large institutions have $8.07M invested in Titan Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+24
Holders Change %
–
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
–
Reduced
–
Closed
–
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$3.38M |
| 2 |
PA
Perceptive Advisors
New York
|
+$2.32M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$337K |
| 4 |
Millennium Management
New York
|
+$277K |
| 5 |
Renaissance Technologies
New York
|
+$275K |
Top Sellers
| 1 |
ECM
Estabrook Capital Management
New York
|
-$724 |
